Skip to Content
Merck
  • Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease.

Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease.

Journal of inherited metabolic disease (1989-01-01)
C J Danpure, P R Jennings, J Mistry, R A Chalmers, R E McKerrell, W F Blakemore, M F Heath
ABSTRACT

This paper concerns an enzymological investigation into a putative feline analogue of the human autosomal recessive disease primary hyperoxaluria type 2. The hepatic activities of D-glycerate dehydrogenase, using both D-glycerate and hydroxypyruvate as substrates, and glyoxylate reductase, which are the deficient enzyme activities in human primary hyperoxaluria type 2, were markedly depleted in four affected cats (0-6% of controls). The activities of a number of other enzymes, lactate dehydrogenase, glutamate dehydrogenase, D-amino acid oxidase, aspartate:2-oxoglutarate amino-transferase, glutamate:glyoxylate aminotransferase and alanine:glyoxylate aminotransferase (the deficient enzyme in primary hyperoxaluria type 1) were unaltered. The intracellular distribution of D-glycerate dehydrogenase and glyoxylate reductase in cat liver was shown to be cytosolic, as they are in human liver. The activities of D-glycerate dehydrogenase and glyoxylate reductase were determined in unaffected related cats and putative heterozygotes were identified. The correlation between D-glycerate dehydrogenase and glyoxylate reductase activities in the related cats and their combined deficiency in the affected cats confirmed previous suggestions that they are identical gene products.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Glyceric acid sodium salt, ≥95.0% (TLC)